Investors

Investors 2017-11-30T21:44:08+00:00

Five-point plan to scale business in a bid to deliver double digit revenue growth, 28 November 2017

Giulio Cerroni, Chief Executive Officer of IXICO, said:

“I have set out a commercially-led growth plan to deliver top-line growth.  We will build on IXICO’s trusted position in providing neuro-imaging technology enabled specialist services to the biopharmaceutical industry across three key value segments:

  • Selecting patients for clinical trials;
  • Assessing safety and efficacy in every phase of drug development; and
  • Post marketing surveillance of marketed medicines.”
CONTACTS & ADVISORS
SHARE PRICE
RNS ANNOUNCEMENTS
SHAREHOLDER INFORMATION
GOVERNANCE
COMPANY DOCUMENTS
FINANCIAL CALENDAR

To speak to one of our experts and find out more

CONTACT US